Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company, on Wednesday announced a 1-for-24 reverse stock split on May 2, which allows the shares to begin trading on a split-adjusted basis from May 3. The reverse stock split intends to increase per share price that supports to maintain the company's listing on the Nasdaq.

农业生物科学公司Yield10 Bioscience，Inc.（YTEN）周三宣布于5月2日进行24对1反向股票分割，这使得这些股票可以从5月3日开始按分割调整后的基础进行交易。反向股票分割旨在提高每股价格，以支持公司在纳斯达克上市。

The reverse stock split will reduce the number of shares from 15,420,951 to 642,539 shares with 60 million authorized shares.Post transaction, the shares will continue to trade on Nasdaq under the symbol 'YTEN' with the new CUSIP number 98585K854. For comments and feedback contact: editorial@rttnews.comBusiness News.

反向股票分割将使股票数量从15420951股减少到642539股，授权股票为6000万股。交易后，这些股票将继续在纳斯达克交易，代码为“YTEN”，新的CUSIP编号为98585K854。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision in March 2024

2024年3月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In November 2023

2023年11月美国食品和药物管理局决定生物技术股